Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: A population-based study

Rheumatology (United Kingdom)

Volumn 52, Issue 1, 2013, Pages 68-75

  Aviña zubieta, J Antonio ^a,b   Abrahamowicz, Michal ^c   De vera, Mary A ^b   Choi, Hyon K ^a,b   Sayre, Eric C ^b   Rahman, M Mushfiqur ^b   Sylvestre, Marie Pierre ^c,d   Wynant, Willy ^c   Esdaile, John M ^a,b,e   Lacaille, Diane ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

Acute myocardial infarction; Cardiovascular disease; Corticosteroids; Glucocorticoids; Rheumatoid arthritis

Indexed keywords

CARDIOVASCULAR AGENT; GLUCOCORTICOID; METHOTREXATE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS;

ADMINISTRATION, ORAL; ADULT; AGED; ARTHRITIS, RHEUMATOID; DATABASES, FACTUAL; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; RISK;

EID: 84871126770     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes353     Document Type: Article

References (49)

1. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
2. Solomon DH, Karlson EW, Rimm EB et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
3. Solomon DH, Goodson NJ, Katz JN et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006;65:1608-12.
4. Maradit-Kremers H, Crowson CS, Nicola PJ et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-11.
5. Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 2008;121(10 Suppl. 1): S9-14.
6. Aviña-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis-a meta-analysis of observational studies. Ann Rheum Dis 2012;71:1524-9.
7. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008; 121(10 Suppl. 1):S21-31.
8. Vaudo G, Marchesi S, Gerli R et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004;63:31-5.
9. Caplan L, Wolfe F, Russell AS, Michaud K. Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes. J Rheumatol 2007;34:696-705.
10. Sholter DE, Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Canadian J Cardiol 2000;16:505-11.
11. Panoulas VF, Douglas KM, Stavropoulos-Kalinoglou A et al. Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. Rheumatology 2008;47:72-5.
12. Brotman DJ, Girod JP, Garcia MJ et al. Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab 2005;90:3202-8.
13. Huiart L, Ernst P, Ranouil X, Suissa S. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. [See comment]. Eur Resp J 2005;25:634-9.
14. Hafezi-Moghadam A, Simoncini T, Yang Z et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 2002;8:473.
15. Suissa S, Assimes T, Brassard P, Ernst P. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med 2003;115:377-81.
16. Davis JM 3rd, Maradit Kremers H, Crowson CS et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007;56:820-30.
17. Souverein PC, Berard A, Van Staa TP et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. [See comment]. Heart 2004;90:859-65.
18. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Int Med 2004;141:764-70.
19. Lacaille D, Anis AH, Guh DP, Esdaile JM. Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 2005;53:241-8.
20. Buttgereit F, Da Silva JAP, Boers M et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 2002; 61:718-22.
21. Buttgereit F, Burmester G-R. Glucocorticoids. In: Klippel JH, Stone JH, Crofford LJ, White PH, eds. Primer on the rheumatic diseases. New York: Springer, 2008,644-50.
22. Abrahamowicz M, Bartlett G, Tamblyn R, du Berger R. Modeling cumulative dose and exposure duration provided insights regarding the associations between benzodiazepines and injuries. J Clin Epidemiol 2006;59: 393-403.
23. Cox DR. Regression models and life-tables. J Roy Stat Soc B 1972;34:187.
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373.
25. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46: 1075-9, discussion 81-90.
26. Dixon WG, Abrahamowicz M, Beauchamp M-E et al. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis 2012;71:1128-33.
27. Aviña-Zubieta JA, Abrahamowicz M, Choi HK et al. Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study. Ann Rheum Dis 2011;70:990-5.
28. Rubin DBP. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757-63.
29. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41.
30. Cadarette SM, Katz JN, Brookhart MA, Sturmer T, Stedman MR, Solomon DH. Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann Intern Med 2008;148:637-46.
31. Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T. Variable selection for propensity score models. Am J Epidemiol 2006;163:1149-56.
32. Akaike H. A new look at the statistical model identification. IEEE Transact Automat Contr 1974;19:716.
33. Abrahamowicz M, Beauchamp M-E, Sylvestre M-P. Comparison of alternative models for linking drug exposure with adverse effects. Stat Med 2011 Advance Access published 17 November 2011, DOI: 10.1002/ sim.4343:n/a-n/a.
34. Schneeweiss S. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf 2006;15:291-303.
35. Ullian ME. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 1999;41:55-64.
36. Won-Jung K, Eun-Mi B, Yoon-Joong K et al. Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques. Immunology 2006;119:421-9.
37. Kato H, Hayashi T, Koshino Y et al. Autocrine production of endothelin-1 participates in the glucocorticoid-induced Ca2+ influx into vascular smooth muscle cells. Biochem Biophys Res Commun 1995;208:82.
38. Petrichenko IE, Daret D, Kolpakova GV, Shakhov YA, Larrue J. Glucocorticoids stimulate cholesteryl ester formation in human smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:1143-51.
39. Mori K, Shioi A, Jono S, Nishizawa Y, Morii H. Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999;19: 2112-8.
40. Huiart L, Ernst P, Ranouil X, Suissa S. Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary disease. Canadian Resp J 2006;13: 134-8.
41. Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004;93:198-200.
42. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Int Med 2004;141:764-70.
43. Davis JM 3rd, Maradit Kremers H, Crowson CS et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007;56:820-30.
44. Chang J, Rogers P, Lacaille D. Can American College of Rheumatology criteria for rheumatoid arthritis be assessed using self-report data?-comparison of self-reported data with chart review. Arthritis Rheum 2011; 63(Suppl. 10):S49.
45. Guan J, Badley EM. Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population. Med Care 2004;42:907-13.
46. Feldman D, Bernatsky S, Haggerty J et al. Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: a population-based study. Arthritis Care Res 2007;57:1419-25.
47. Levy AR, Tamblyn RM, Fitchett D, McLeod PJ, Hanley JA. Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. Canadian J Cardiol 1999;15:1277-82.
48. Austin PC, Daly PA, Tu JV. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J 2002;144:290-6.
49. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004;148:99.